I-Steroids kanye nama-immunomodulators bangaphatha i-Psoriasis ebusweni
I-psoriasis ebusweni, ehlasela abantu abangaba ngu-46% abane-psoriasis, ikhiqiza izilinganiso ze-silvery, ama-rashes amahle futhi, ezimweni ezingavamile, izilonda ezivulekile endaweni yomzimba onzima ukuyifihla. Ngenxa yalokho, labo abane-psoriasis ebusweni babhekana nezinselela ezihlukene, ezibandakanya kokubili ukwelashwa nezindlela zokubhekana nazo
Ukuxilongwa kwe-Facial Psoriasis
Esimweni kanye nezimpawu zayo, i-psoriasis ebusweni ayifani ne-psoriasis evela kwenye indawo.
Ngaphezu kwakho konke, abantu abane-psoriasis ebusweni bavame ukuzwa ukushisa okufanayo, okusabalalisa kunoma yiluphi uhlobo lwe-psoriasis.
Ukuqhuma ngokuvamile kuthinta isikhumba ngaphezu kwenkaba eliphezulu, kanye nezindawo ezungeze ebunzini nasemaceleni, nasezinwele. Ngokwesinye isifundo saseKorea seziguli ezingu-235 ezine-psoriasis ebusweni, abahlanganyeli abangaba ngu-74% base bevele bexosha ebunzini eliphezulu, futhi cishe u-46% waba nemisipha eduze kwendlebe. Ucwaningo lubuye lwathola ukuthi iziguli eziningi zaqala ukubona izimpawu zobuso phakathi kweminyaka engama-30 kuya ku-40.
Ukuze uhlolisise i-psoriasis ebusweni, udokotela uzohlola isikhumba sesiguli futhi uzothatha umlando wempilo yakhe. Uma ukuxilongwa kungabaza, i-biopsy ingenziwa ukuze ilawulwe ezinye izifo zesikhumba, njenge- seborrheic dermatitis .
Izinketho zokwelashwa ze-Psoriasis ebusweni
Njenge psoriasis ejwayelekile, i-psoriasis ebusweni ngokuvamile iphendula kahle kuma- moisturizers kanye ne-petroleum jelly.
Abantu abane-psoriasis ebusweni kufanele baqaphele ukuthi yini eyenza abantu bahlasele , njengoba le misebenzi noma imikhiqizo kufanele igwenywe. Isibonelo, abanye abantu babika ama-flare-ups ngemuva kokubhukuda echibini elihlotshisiwe, kanti abanye abantu bathi amanzi achloride empeleni athuthukisa izimpawu.
Izindlela zokwelapha eziningi ze-steroid ezivunyiwe ezivunyelwe ukwelashwa kwe-psoriasis, njenge-hydrocortisone creams, zingase zisebenze kahle ekuphatheni i-psoriasis ebusweni. Kodwa ukusebenzisa ama-steroid anjalo kufanele kube nokulinganiselwe, njengoba ukusetshenziswa kwesikhathi eside kungabangela ukukhunta isikhumba kanye neminye imiphumela emibi. Khuluma nodokotela wakho mayelana nokwelashwa kwe-steroid kanye nezici eziyingozi.
I-protopic (i-tacrolimus) , okuyi-immunomodulator, isetshenziselwa ukwelashwa okungekho emkhatsini we-label we-facial and i-psoriasis yesisu. I-protopic yisidakamizwa sokuzivikela esivunyelwe ukusiza ekuvimbeleni ukwenqatshwa kwezitho ezifakelwe kabusha. I-FDA ixwayisa ukuthi i-Protopic akufanele ithathwe njengendlela yokwelashwa kokuqala kwe-psoriasis nokuphathwa kwayo kufanele ihlolwe ngokucophelela ngudokotela owaziyo. I-ejensi yokulawula ibuye iyala umenzi ukuthi afake isaziso sebhokisi elimnyama ephawula ukuthi imithi ihlobene nengozi eyengeziwe yomdlavuza wesikhumba, i-lymphoma, kanye nezifo ezithathelwanayo. Isixwayiso sebhokisi elimnyama yilona ilebula eliyisiqalo esinamandla kunayo yonke i-ejensi esebenzisa.
I-protopic, evame ukusetshenziswa kabili ngosuku, isebenza ngokuvimbela umcabango wokuphendula nge-immune ukuze kubangele izimpawu ze-psoriasis. Iziguli ezisebenzisa i-Protopic kufanele zithinte udokotela ngokushesha uma zizwa izigulane ezivuvukala, umkhuhlane, ukukhathala, izilonda ezibandayo noma ukugcoba noma ukuvuvukala kwesikhumba.
Ezinye imiphumela ezingathí sina ezingathí sina ezingathí sina zibandakanya ukuzwa okuthinta indawo kwisayithi lesicelo, ukulunywa, ukugcoba, ukucabangela, nokukhanda ikhanda.
Ucwaningo oluncane lwango-2007, olwanyatheliswa kuyi- British Journal of Dermatology , lwaqhathanisa ukusebenza kwe-calcitriol yama-topical kanye ne-tacrolimus. Ucwaningo lwamasonto ayisithupha, olubandakanya abahlanganyeli abangu-50 nge-facial or psitalas psoriasis, lithole ukuthi iziguli ezingu-60% ezithatha i-tacrolimus zithole imvume ephelele noma ephelele ye-psoriasis ukushona nokulonda. Kodwa-ke, kuphela izigulane ezingama-33% ezisebenzisa i-calcitriol ezenzeke ngcono.
Izinkinga zokuzibheka kanye ne-Psoriasis ebusweni
Ngenxa yokuthi i-psoriasis ebusweni akulula ukumboza noma imaski, ithwala izinselele ezihlukahlukene zengqondo ezingabhekana nalabo abane-psoriasis engekho ebusweni.
Noma kunjalo lezi zinselelo zingenakunqotshwa, ngokubambisana okulungile kokwelashwa nokusekelwa.
I-Mayo Clinic iluleka iziguli ukuba zifundise umndeni nabangane mayelana ne-psoriasis ebusweni kanye nezindlela zokwelashwa eziphakanyiswe odokotela. Lokhu kuvumela ukuba babe yingxenye yesisombululo. Ukuthola iqembu lokusekela kungasiza futhi, njengoba kungakhuluma nomeluleki mayelana nezindaba ezingokomzwelo ezihlobene nalesi sifo.
Iziguli ezine-psoriasis ebusweni zingabuye zenze izinto ezihlukahlukene zokumboza. I-National Psoriasis Foundation incoma i-Dermablend, izimonyo ezenzelwe abantu abane-psoriasis, i-dermatitis nezinye izimo zesikhumba. Kodwa-ke, isisekelo sineluleka ngokusebenzisa izimonyo esikhumbeni esicasuliwe ngokweqile noma izilonda ezingavaliwe, njengoba lokhu kungabangela ukugula nokutheleleka okungenzeka.
Imithombo:
"I-American Academy of Dermatology iyaphendula isinqumo se-FDA ngemithi ye-Eczema." I-American Academy of Dermatology. 19 JAN 2006. I-American Academy of Dermatology.
"I-Calcipotriene Topical." Imininingwane yeDruglinePlus. 2008. Izikhungo zezempilo zikazwelonke.
"I-Calcitriol." Imininingwane yeDruglinePlus. 2007. Izikhungo zezempilo zikazwelonke.
Fortune, DG, HL Richards, CJ Main, kanye neCEM Griffiths. "Amasu Amagciwane Wokubhekana Ne-Psoriasis." Izidakamizwa zemithi. 27. 3. Meyi 2002. 177-184.
"I-Hydrocortisone Topical." Imininingwane yeDruglinePlus . 2007. Izikhungo zezempilo zikazwelonke.
Liao, YH, HC Chiu, YS Tseng, no-TF Tsai. "Ukuqhathaniswa nokubekezela okuncane nokusebenza kweCalcitriol 3 I-Microg g (-1) Amafutha kanye ne-Tacrolimus 0.3 mg g (-1) Amafutha e-Plaque Psoriasis ehlanganisa i-Facial Facial or Genitofemoral Areas: I-Trial-Blind, e-Randomised Control Trial." I-British Journal ye-Dermatology. 157. 5. Nov. 2007. 1005-12.
"Ukuphila nge-Psoriasis: Ukufihla nokumboza." I-National Psoriasis Foundation: Isifihle kanye nokumboza . 2008. National Psoriasis Foundation.
Abasebenzi beMayo Clinic. "Psoriasis: Ukubhekana Nekhono." I-Mayo Clinic.com . 20 Mashi 2007. I-Mayo Clinic.
"Ishidi Lolwazi Lokubekezela: I-Tacrolimus Oil." Isikhungo Sokuhlolwa Kwezidakamizwa Nokucwaninga . May 2006. Ukuphathwa Kwezokudla Nezidakamizwa.
"I-Psoriasis kwiSayithi Ezingqayizivele Zesikhumba: I-Psoriasis Ebusweni." I-National Psoriasis Foundation: I-Psoriasis ku-Face . Okthoba 2005. National Psoriasis Foundation.
Van de Kerkhof, PC, GM Murphy, J. Austad, A. Ljungberg, F. Cambazard, noLB Duvold. "Psoriasis of the Face and Flexures." I-Journal of Dermatological Treatment. 18. 6. 2007. 351-360.
Yoon, HS, JY Park, noJL Youn. "Ukufundiswa Kwemitholampilo Ye-Psoriasis Esibusweni." I-Korean Journal of Dermatology. 44. 12. Dec. 2006. 1397-1402.